[RCKT] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[RCKT] Rocket Pharmaceuticals, Inc.
Announcement Date
04-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -4.45%
YoY- -13.78%
Quarter Report
RCKT's Result
RCKT's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -65,701 -58,335 -66,723 -57,756 -54,402 -42,982 -44,247 30.24%
Tax 3,524 -3,391 -2,358 -732 192 418 1,264 98.46%
NP -65,701 -54,944 -64,365 -57,024 -54,594 -43,400 -44,247 30.24%
Tax Rate - - - - - - - -
Total Cost 65,701 54,944 64,365 57,024 54,594 43,400 44,247 30.24%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.82 -0.69 -0.88 -0.86 -0.83 -0.67 -0.69 12.23%
EPS Diluted -0.82 -0.69 -0.88 -0.86 -0.83 -0.67 -0.69 12.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.